Abstract P1-14-01: Final results of NorBreast-231, a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel as first-line chemotherapy in patients with advanced breast cancer

Mapping Intimacies ◽

10.1158/1538-7445.sabcs18-p1-14-01 ◽

2019 ◽

Author(s):

MS Aapro ◽

R Hegg ◽

M Ruiz Borrego ◽

E Staroslawska ◽

S Morales ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

First Line ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

European Journal of Cancer ◽

10.1016/0959-8049(95)95599-2 ◽

1995 ◽

Vol 31 ◽

pp. S75 ◽

Cited By ~ 1

Author(s):

R. Paridaens ◽

P. Bruning ◽

F. Calabresi ◽

A. Awada ◽

J.A. Roy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)

Annals of Oncology ◽

10.1093/annonc/mdi056 ◽

2005 ◽

Vol 16 (2) ◽

pp. 253-258 ◽

Cited By ~ 59

Author(s):

L. Del Mastro ◽

F. Perrone ◽

L. Repetto ◽

L. Manzione ◽

V. Zagonel ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

First Line ◽

Line Chemotherapy

Download Full-text

Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial)

The Breast ◽

10.1016/j.breast.2019.01.009 ◽

2019 ◽

Vol 45 ◽

pp. 7-14 ◽

Cited By ~ 2

Author(s):

Matti Aapro ◽

Manuel Ruiz-Borrego ◽

Roberto Hegg ◽

Bozena Kukielka-Budny ◽

Serafin Morales ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Estrogen Receptor Positive

Download Full-text

NorBreast-231 trial: a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor positive, HER2-negative patients with advanced breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(18)30523-9 ◽

2018 ◽

Vol 92 ◽

pp. S98

Author(s):

M. Ruiz Borrego ◽

R. Hegg ◽

E. Staroslawska ◽

S. Morales ◽

S. Cinieri ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Estrogen Receptor Positive

Download Full-text

Abstract P6-14-03: Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial)

10.1158/1538-7445.sabcs17-p6-14-03 ◽

2018 ◽

Author(s):

M Aapro ◽

M Ruiz Borrego ◽

E Staroslawska ◽

S Morales ◽

S Cinieri ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Estrogen Receptor Positive

Download Full-text

Reply to “Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)” by L. Del Mastro et al. (Ann Oncol 2005; 16: 253–258)

Annals of Oncology ◽

10.1093/annonc/mdi386 ◽

2005 ◽

Vol 16 (12) ◽

pp. 1979

Author(s):

C.H. Smorenburg ◽

A.J. ten Tije

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

First Line ◽

Line Chemotherapy

Download Full-text

Randomised Phase Ii Study Evaluating, As First-Line Chemotherapy, Weekly Oral Vinorelbine As a Single-Agent Versus Weekly Paclitaxel As a Single-Agent in Estrogen Receptor Positive, Her2-Negative Patients with Advanced Breast Cancer (Norbreast-231 Trial)

Annals of Oncology ◽

10.1093/annonc/mdu329.63 ◽

2014 ◽

Vol 25 ◽

pp. iv136

Author(s):

M. Aapro ◽

E. Staroslawska ◽

S. Morales ◽

M. Ruiz Borrego ◽

S. Cinieri ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

First Line ◽

Oral Vinorelbine ◽

Estrogen Receptor Positive ◽

Line Chemotherapy

Download Full-text

Abstract CT101: Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)

10.1158/1538-7445.am2014-ct101 ◽

2014 ◽

Cited By ~ 23

Author(s):

Richard S. Finn ◽

John P. Crown ◽

Istvan Lang ◽

Katalin Boer ◽

Igor M. Bondarenko ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Cyclin Dependent Kinase ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Abstract OT3-02-04: Randomised phase II study evaluating, as first-line chemotherapy, single-agent oral vinorelbine administered with two different schedules in patients with hormone receptor positive, HER2-negative advanced breast cancer (TempoBreast-1 trial)

10.1158/1538-7445.sabcs15-ot3-02-04 ◽

2016 ◽

Cited By ~ 1

Author(s):

J De la Haba ◽

M Cazzaniga ◽

G Freyer ◽

L Costa ◽

E Petru ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Single Agent ◽

First Line ◽

Oral Vinorelbine ◽

Hormone Receptor Positive ◽

Line Chemotherapy

Download Full-text

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC

British Journal of Cancer ◽

10.1038/bjc.1996.416 ◽

1996 ◽

Vol 74 (4) ◽

pp. 650-656 ◽

Cited By ~ 58

Author(s):

V Dieras ◽

◽

B Chevallier ◽

P Kerbrat ◽

I Krakowski ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line ◽

Clinical Screening ◽

Multicentre Phase ◽

Line Chemotherapy

Download Full-text